Skip to main content
OpenTrials

Clinical trial condition

Recurrent Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Recurrent Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

43 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Head and Neck Squamous Cell Carcinoma trial results

Completed

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

NCT03422536

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +41 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions